Aegis Elixirs Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
- Paid Up Capital ₹ 5.50 M
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.63 Cr
- Revenue Growth 102.50%
- Profit Growth 650.97%
- Ebitda 214.61%
- Net Worth 1858.73%
- Total Assets -13.03%
About Aegis Elixirs
Aegis Elixirs Limited (AEL) is a Public Limited Indian Non-Government Company incorporated in India on 16 April 2002 and has a history of 22 years and nine months. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.50 M.
The company has closed loans amounting to ₹1.63 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Seema Gupta, Ajay Gupta, and Sachin Gupta serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232PB2002PLC025077
-
Company No.
025077
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
16 Apr 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Aegis Elixirs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Gupta
|
Director | 16-Apr-2002 | Current |
|
Ajay Gupta
|
Director | 16-Apr-2002 | Current |
|
Sachin Gupta
|
Director | 16-Apr-2002 | Current |
Financial Performance of Aegis Elixirs.
Aegis Elixirs Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 102.5% increase. The company also saw a substantial improvement in profitability, with a 650.97% increase in profit. The company's net worth Soared by an impressive increase of 1858.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aegis Elixirs?
In 2020, Aegis Elixirs had a promoter holding of 96.36% and a public holding of 3.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹16.31 M
Charges Breakdown by Lending Institutions
- Others : 1.03 Cr
- Punjab National Bank : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2014 | Others | ₹1.03 Cr | Satisfied |
| 18 Sep 2013 | Punjab National Bank | ₹6.00 M | Satisfied |
How Many Employees Work at Aegis Elixirs?
Unlock and access historical data on people associated with Aegis Elixirs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aegis Elixirs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aegis Elixirs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
